Literature DB >> 31862224

Risk factors of bone mineral metabolic disorders.

Alicia Montaner Ramón1.   

Abstract

Bone remodeling is a complex process which integrates different stimuli factors such as mechanical, nutritional and hormonal factors as well as cytokines and growth factors. Bone health depends on an adequate balance between all these factors. The typical bone pathology of the newborn is the metabolic bone disease of prematurity, favored by a lack of mineral accretion in the third trimester of gestation. The intrinsic defects of the bone tissue (primary osteoporosis) are usually of genetic or idiopathic origin and can affect both the term and the preterm newborn. Other risk factors for osteopenia (secondary osteoporosis) include maternal or gestational factors, nutritional deficits (calcium, phosphorus, vitamin D), endocrinological alterations, use of certain medications antagonistic to bone metabolism, mechanical factors and chronic diseases (renal or hepatic insufficiency, intestinal malabsorption, collagen or metabolic diseases). This review examines the risk factors of developing bone metabolic disorders in neonates.
© 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcium; Metabolic bone disease; Neonates; Osteopenia; Prematurity; Vitamin D

Year:  2019        PMID: 31862224     DOI: 10.1016/j.siny.2019.101068

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  4 in total

Review 1.  Disorders of phosphate homeostasis in children, part 1: primer on mineral ion homeostasis and the roles of phosphate in skeletal biology.

Authors:  Richard M Shore
Journal:  Pediatr Radiol       Date:  2022-05-10

2.  Metabolic Bone Disease of Prematurity: Risk Factors and Associated Short-Term Outcomes.

Authors:  Alejandro Avila-Alvarez; Adela Urisarri; Jesús Fuentes-Carballal; Natalia Mandiá; Andrea Sucasas-Alonso; María L Couce
Journal:  Nutrients       Date:  2020-12-10       Impact factor: 5.717

3.  Incidence, Risk Factors and Prediction of Secondary Hyperparathyroidism in Preterm Neonates under 32 Weeks' Gestational Age.

Authors:  Alejandro Avila-Alvarez; Helena Perez Tato; Andrea Sucasas Alonso; Ana Prado Carro; Jesus Fuentes Carballal
Journal:  Nutrients       Date:  2022-08-18       Impact factor: 6.706

4.  Analysis of the Clinical Features of Intrauterine Ureaplasma urealyticum Infection in Preterm Infants: A Case-Control Study.

Authors:  Tong Sun; Jianhua Fu
Journal:  Front Pediatr       Date:  2021-12-09       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.